Update: Routine screening for antibodies to human immunodeficiency virus, civilian applicants for U.S. military service and U.S. Armed Forces, active and reserve components, January 2013-June 2018.
This report provides an update through June 2018 of the results of routine screening for antibodies to the human immunodeficiency virus (HIV) among civilian applicants for military service and among members of the active and reserve components of the U.S. Armed Forces. During the surveillance period, full-year seroprevalences among applicants for service peaked in 2015 (0.34 per 1,000 tested) and then decreased during the subsequent 2 years (0.33 and 0.26 per 1,000 tested, respectively). Seroprevalences among Army active component service members, Navy active component members, Navy reservists, Marine Corps reservists, and Air National Guard members also peaked in 2015. Overall (1 January 2013 through 30 June 2018) seroprevalences were highest for Army reservists, Army National Guard members, Navy reservists, and Navy active component members. Across active and reserve components of all services, HIV antibody seroprevalences continued to be higher among males than females.